Abstract Proceedings of ICIRESM – 2020
Full conference PDF is available to the subscribed user. Use your subscription login to access,
NEW FAMILY PART OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE
KIBRA, originally identified as a protein expressed predominantly in KIDney and BRAin, has been shown to be highly expressed in breast cancer cells and plays an important role in growth and survival of breast cancer cells. Since KIBRA is widely expressed in breast cancer cells and because cell survival functions of KIBRA might counteract DNA-damage response. Our in vitro, in vivo data and from ATM over expression and ATM null model systems provide evidence that KIBRA is a physiological substrate of Ataxia Telangiectasia Mutated Kinase (ATM) - a master regulator of DNA Damage Response (DDR) pathway. We identified the site of phosphorylation by site directed mutagenesis, and further confirmed the same with motif specific antibody. Our work introduced KIBRA in ATM kinase family
KIBRA, Ataxia Telangiectasia Mutated Kinase (ATM)
13/11/2020
117
20117
IMPORTANT DAYS
Paper Submission Last Date
October 20th, 2024
Notification of Acceptance
November 7th, 2024
Camera Ready Paper Submission & Author's Registration
November 1st, 2024
Date of Conference
November 15th, 2024
Publication
January 30th, 2025